JoVE Logo
Faculty Resource Center

Sign In

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

DOI :

10.3791/53836-v

13:24 min

April 11th, 2016

April 11th, 2016

11,498 Views

1Asuragen, Inc.

An integrated system for targeted next-generation sequencing of oncology specimens is described. This cross-platform system is optimized for low-quality and low-quantity tumor biopsies, accommodates low DNA inputs, includes well-characterized multi-variant controls, and features a novel variant caller that is informed by quantitative pre-analytical quality control measures.

Tags

Integration

-- Views

Related Videos

article

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma

article

Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies

article

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics

article

Collection and Extraction of Saliva DNA for Next Generation Sequencing

article

A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies

article

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

article

Isolation and Culture Expansion of Tumor-specific Endothelial Cells

article

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies

article

Manufacture of a Multi-Purpose Low-Cost Animal Bench-Model for Teaching Tracheostomy

article

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved